NBL-015

DB18183InvestigationalProtein Based Therapies

NBL-015: Overview.

Also known as
Fully human monoclonal IgG1 antibody against the type 2 isoform of human Claudin 18 protein (Claudin 18.2). · NBL-015 (ANTI-CLAUDIN18.2 MAB)
Code names
FL-301 · NBL 015

Resolves to

What you can answer from here — as of September 21, 2023

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of NBL-015, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account